Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 22204-53-1 | Product Number: M1021
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic Acid
×
![]()
×
Purity: >99.0%(GC)(T)
Synonyms:
- (S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid
- Naproxen
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 25G |
$35.00
|
15 | 1 | ≥80 |
|
| 500G |
$413.00
|
26 | Contact Us | 13 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | M1021 |
| Purity / Analysis Method | >99.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__1__4H__1__4O__3 = 230.26 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
| CAS RN | 22204-53-1 |
| Reaxys Registry Number | 3591067 |
| PubChem Substance ID | 87572993 |
| SDBS (AIST Spectral DB) | 19020 |
| Merck Index (14) | 6417 |
| MDL Number | MFCD00010500 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 99.0 % |
| Purity(Neutralization titration) | min. 99.0 % |
| Melting point | 155.0 to 158.0 °C |
| Specific rotation [a]20/D | +65.0 to +70.0 deg(C=1, CHCl3) |
Properties (reference)
| Melting Point | 155 °C |
| Specific Rotation | 67.5° (C=1,CHCl3) |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | UF5275000 |
Transport Information:
| UN Number (DOT-AIR) | UN2811 |
| Class (DOT-AIR) | 6.1 |
| Packing Group (TCI-A) | III |
| HS Number | 2918.99.4700 |
Application
(S)-Naproxen: A Nonselective COX-1 and COX-2 Enzymes Inhibitor
(S)-Naproxen, a propionic acid derivative with a naphthalene nucleus, is a nonselective nonsteroidal anti-inflammatory drug (NSAID) and the pharmacologically active enantiomer of (±)-naproxen [M1220]. (S)-Naproxen works by reversibly inhibiting both the COX-1 and COX-2 enzymes. It had twice the potency of (S)-(+)-ibuprofen [I0549] and a longer half-life (ca. 12 hours). (S)-naproxen is a more active form than the (R)-naproxen which causes liver damage. (The product is for research purpose only.)
References
- Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states (a review)
- Clinical pharmacokinetics of naproxen (a review)
- Twenty years of naproxen technology (a review)
- Photoreactivity of the nonsteroidal anti-inflammatory 2-arylpropionic acids with photosensitizing side effects (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.